Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Urease enzyme from Helicobacter pylori is a multi-subunit, nickel-dependent metalloenzyme essential for the bacterium’s survival in the acidic environment of the human stomach[3][5][6]. The enzyme rapidly hydrolyzes urea, which diffuses into the bacterial cytoplasm via a specialized proton-gated urea channel, forming ammonia and carbon dioxide[7]. The ammonia produced locally neutralizes gastric acid, allowing H. pylori to maintain intracellular and periplasmic pH homeostasis, which is vital for colonization and persistent infection[6][8]. Structurally, H. pylori urease is a dodecameric assembly containing 12 UreA and 12 UreB subunits, with the active site featuring two nickel ions bridged by a carbamylated lysine and surrounded by several histidines and an aspartate[1][7]. Maturation and activation of the enzyme require several accessory proteins (UreD, UreE, UreF, UreG, and UreH), responsible for nickel insertion and proper folding[2][3]. Because urease is both essential for gastric colonization and unique to H. pylori among stomach bacteria, it is a major target for diagnostic tests and drug development, and its inhibition is a validated strategy for eradicating H. pylori infection and ameliorating gastritis, ulcers, and some gastric cancers[1][7][6].
Inhibition of urease active site, disruption of nickel binding or incorporation into the enzyme, and inhibition of urea hydrolysis, reducing ammonia production and acid resistance.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Urease enzyme from Helicobacter pylori.